143 related articles for article (PubMed ID: 22690339)
1. Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health system.
Simon MS; Lamerato L; Krajenta R; Booza JC; Ruterbusch JJ; Kunz S; Schwartz K
Int J Breast Cancer; 2012; 2012():453985. PubMed ID: 22690339
[TBL] [Abstract][Full Text] [Related]
2. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in breast cancer survival in a large urban integrated health system.
Roseland ME; Pressler ME; Lamerato LE; Krajenta R; Ruterbusch JJ; Booza JC; Schwartz K; Simon MS
Cancer; 2015 Oct; 121(20):3668-75. PubMed ID: 26110691
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
[TBL] [Abstract][Full Text] [Related]
5. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
6. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
[TBL] [Abstract][Full Text] [Related]
8. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.
Sail K; Franzini L; Lairson D; Du X
Ethn Health; 2012; 17(3):309-23. PubMed ID: 22066691
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in survival of female breast cancer in the Detroit metropolitan area.
Simon MS; Severson RK
Cancer; 1996 Jan; 77(2):308-14. PubMed ID: 8625239
[TBL] [Abstract][Full Text] [Related]
10. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
[TBL] [Abstract][Full Text] [Related]
11. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in treatment and survival from ovarian cancer.
Hildebrand JS; Wallace K; Graybill WS; Kelemen LE
Cancer Epidemiol; 2019 Feb; 58():77-82. PubMed ID: 30528360
[TBL] [Abstract][Full Text] [Related]
13. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.
Yeboa DN; Xu X; Jones BA; Soulos P; Gross C; Yu JB
Am J Clin Oncol; 2016 Dec; 39(6):568-574. PubMed ID: 24879475
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in functional disability among older women with newly diagnosed nonmetastatic breast cancer.
Owusu C; Schluchter M; Koroukian SM; Mazhuvanchery S; Berger NA
Cancer; 2013 Nov; 119(21):3839-46. PubMed ID: 24114615
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer.
Reeder-Hayes KE; Meyer AM; Dusetzina SB; Liu H; Wheeler SB
Breast Cancer Res Treat; 2014 Jun; 145(3):743-51. PubMed ID: 24789443
[TBL] [Abstract][Full Text] [Related]
17. Racial disparities in treatment and survival among women with early-stage breast cancer.
Hershman D; McBride R; Jacobson JS; Lamerato L; Roberts K; Grann VR; Neugut AI
J Clin Oncol; 2005 Sep; 23(27):6639-46. PubMed ID: 16170171
[TBL] [Abstract][Full Text] [Related]
18. Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US.
Lipscomb J; Gillespie TW; Goodman M; Richardson LC; Pollack LA; Ryerson AB; Ward KC
Breast Cancer Res Treat; 2012 May; 133(1):285-96. PubMed ID: 22278190
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.
Felder TM; Do DP; Lu ZK; Lal LS; Heiney SP; Bennett CL
Breast Cancer Res Treat; 2016 May; 157(1):193-200. PubMed ID: 27120468
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
